I'll say; I was expecting +/- 55c on the back of the US DoD writing a blank cheque to get this drug over the finish line.
Then +/- 80c upon further positive results of PCSK9 inhibitor proof of concept study in June/July.
When you consider the sheer lack of shares available to the public if even just one of these drugs reaches the market... It's retirement stock on the dividends alone.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $51.67M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 25.0¢ | 23.0¢ | $143.6K | 590.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60000 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 159081 | 1 |
View Market Depth
| Last trade - 15.59pm 20/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |